News Sanofi’s R&D platform building continues with $6bn-plus IGM deal Phil Taylor antibody, GM Biosciences, Immunology and inflammation, Oncology, partnering, Sanofi 0 Comment Sanofi has agreed another deal to flesh out its R&D pipeline, paying IGM Biosciences $150 million upfront to Share X Sanofi’s R&D platform building continues with $6bn-plus IGM deal https://pharmaphorum.com/news/sanofis-rd-platform-building-continues-with-6bn-plus-igm-deal/